Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biocryst Pharma Inc (NQ: BCRX )

9.065 USD +0.265 (+3.01%)
Official Closing Price Updated: 7:59 PM EST, Jan 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Biocryst Pharma Inc

< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
European Medicines Agency Validates Marketing Authorization Application for Oral, Once-Daily Berotralstat (BCX7353) to Prevent HAE Attacks
From GlobeNewswire News Releases
BEROTRALSTAT (BCX7353) SIGNIFICANTLY REDUCED USE OF ACUTE ON-DEMAND MEDICINE IN HAE PATIENTS IN APEX-2
From GlobeNewswire News Releases
BioCryst Reports Fourth Quarter and Full Year 2019 Financial Results and Upcoming Key Milestones
From GlobeNewswire News Releases
BioCryst Begins Proof of Concept Trial in PNH Patients With Oral Factor D Inhibitor, BCX9930
Data from proof of concept trial expected in 2Q 2020 
From GlobeNewswire News Releases
BioCryst to Present at Barclays Global Healthcare Conference
From GlobeNewswire News Releases
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
From GlobeNewswire News Releases
BioCryst to Present New Data at American Academy of Allergy, Asthma & Immunology Annual Meeting
From GlobeNewswire News Releases
BioCryst Appoints Alan G. Levin to Board of Directors
From GlobeNewswire News Releases
BioCryst to Report Fourth Quarter and Full Year 2019 Financial Results on March 5
From GlobeNewswire News Releases
FDA Accepts BioCryst’s NDA for Oral, Once Daily Berotralstat (BCX7353) to Prevent HAE Attacks
PDUFA date is December 3, 2020 
From GlobeNewswire News Releases
BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
BioCryst Submits Japanese New Drug Application for Oral, Once Daily Berotralstat
From GlobeNewswire News Releases
Global Glioblastoma Multiforme Drugs Market Projected Could Reach $1.4 Billion By 2025
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Global Glioblastoma Multiforme Drugs Market Projected Could Reach $1.4 Billion By 2025
Financialnewsmedia.com News Commentary 
From PR Newswire
World Health Organization Accelerating Diagnostics, Vaccines, Therapeutics For Novel Coronavirus
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
World Health Organization Accelerating Diagnostics, Vaccines, Therapeutics For Novel Coronavirus
Financialnewsmedia.com News Commentary 
From PR Newswire
Hopeful New Therapies For Pancreatic Cancer Expected To Be a Big Boon for Biotechs
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Hopeful New Therapies For Pancreatic Cancer Expected to be a Big Boon for Biotechs
Financialnewsmedia.com News Commentary 
From PR Newswire
BioCryst Strengthens Commercial Rare Disease Leadership
From GlobeNewswire News Releases
BioCryst to Provide Berotralstat and BCX9930 Program Updates at 38th Annual J.P. Morgan Healthcare Conference
From GlobeNewswire News Releases
BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
From GlobeNewswire News Releases
BioCryst to Present at 38th Annual J.P. Morgan Healthcare Conference
From GlobeNewswire News Releases
BioCryst Submits New Drug Application for Oral, Once Daily Berotralstat (BCX7353) to Prevent HAE Attacks
From GlobeNewswire News Releases
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Why The Global Pain Management Drug Market Is Adopting More Non-Opioid Options
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Why the Global Pain Management Drug Market is Adopting More Non-Opioid Options
Financialnewsmedia.com News Commentary 
From PR Newswire
BioCryst Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares and Completion of Public Offering of Common Stock
From GlobeNewswire News Releases
BioCryst to Present at Upcoming Investor Conferences
From GlobeNewswire News Releases
BioCryst Prices Public Offering of Common Stock
From GlobeNewswire News Releases
BioCryst Commences Public Offering of Common Stock
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
25 26 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account